LSE creators

Number of items: 15.
Health Policy
  • Fontrier, Anna-Maria, Kamphuis, Bregtje W., Kanavos, Panos (2023). How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe. European Journal of Health Economics, https://doi.org/10.1007/s10198-023-01637-z picture_as_pdf
  • Fontrier, Anna-Maria (2023). Entry to market of new medicines and medicines treating rare diseases: issues arising from value assessment processes in the European Union, the United Kingdom and Canada [Doctoral thesis]. London School of Economics and Political Science. https://doi.org/10.21953/lse.00004621
  • Apostolou, Efstratios A., Fontrier, Anna Maria, Efthimiadis, Georgios K., Kastritis, Efstathios, Parissis, John, Kanavos, Panos (2023). The patient pathway in ATTR-CM in Greece and how to improve it: a multidisciplinary perspective. Hellenic Journal of Cardiology, 73(September–October 20), 73 - 80. https://doi.org/10.1016/j.hjc.2023.05.004 picture_as_pdf
  • Fontrier, Anna-Maria, Kanavos, Panos (2023). Do reimbursement recommendations by the Canadian Agency for Drugs and Technology in Health translate into coverage decisions for orphan drugs in the Canadian province of Ontario? Value in Health, 26(7), 1011 - 1021. https://doi.org/10.1016/j.jval.2023.02.013 picture_as_pdf
  • Gill, Jennifer, Chávez, Danitza, Main, Caitlin, Miracolo, Aurelio, Fontrier, Anna-Maria, Kanavos, Panos (2023). Sustainable healthcare financing for SDG3 in ASEAN-6. Medical Technology Research Group (MTRG), The London School of Economics and Political Science. https://doi.org/10.21953/lse.n02sh3yxlet8 picture_as_pdf
  • Fontrier, Anna-Maria (2022). Market access for medicines treating rare diseases: association between specialised processes for orphan medicines and funding recommendations. Social Science & Medicine, 306, https://doi.org/10.1016/j.socscimed.2022.115119 picture_as_pdf
  • Fontrier, Anna-Maria, Visintin, Erica, Kanavos, Panos (2022). Similarities and differences in Health Technology Assessment systems and implications for coverage decisions: evidence from 32 countries. PHARMACOECONOMICS-OPEN, 6(3), 315 - 328. https://doi.org/10.1007/s41669-021-00311-5 picture_as_pdf
  • Kamphuis, Bregtje, Fontrier, Anna-Maria, Haig, Madeleine, Politopoulou, Konstantina, Salyga, Hana, Gentilini, Arianna, Kanavos, Panos (2021). Development of policies to increase headroom for innovation in Egypt and the Kingdom of Saudi Arabia. LSE Consulting. picture_as_pdf
  • Kamphuis, Bregtje, Fontrier, Anna-Maria, Gill, Jennifer, Efthymiadou, Olina, Salyga, Hana, Kanavos, Panos (2021). Access to medicines in Europe delays and challenges for patient access: delays and challenges for patient access. LSE Consulting.
  • Kanavos, Panos, Kamphuis, Bregtje W., Fontrier, Anna-Maria, Parkin, Georgia Colville, Saleh, Shadi, Akhras, Kasey S. (2020). Pricing of in-patent pharmaceuticals in the Middle East and North Africa is external reference pricing implemented optimally? Health Policy, 124(12), 1297 - 1309. https://doi.org/10.1016/j.healthpol.2020.07.017 picture_as_pdf
  • Gill, Jennifer, Fontrier, Anna-Maria, Miracolo, Aurelio, Kanavos, Panos (2020). Access to personalised oncology in Europe.
  • Gill, Jennifer, Fontrier, Anna-Maria, Kyriopoulos, Dionysis, Kanavos, Panos (2019). Variations in external reference pricing implementation does it matter for public policy? European Journal of Health Economics, 20(9), 1375 - 1397. https://doi.org/10.1007/s10198-019-01100-y description
  • Fontrier, Anna-Maria, Gill, Jennifer, Kanavos, Panos (2019). International impact of external reference pricing should national policy makers care? European Journal of Health Economics, 20(8), 1147 - 1164. https://doi.org/10.1007/s10198-019-01083-w picture_as_pdf
    • LSE
  • Kamphuis, Bregtje, Fontrier, Anna-Maria, Haig, Madeleine, Politopoulou, Konstantina, Salyga, Hana, Gentilini, Arianna, Kanavos, Panos (2021). Development of policies to increase headroom for innovation in Egypt and the Kingdom of Saudi Arabia. LSE Consulting. picture_as_pdf
  • Kanavos, Panos, Fontrier, Anna-Maria, Gill, Jennifer, Efthymiadou, Olina, Boekstein, Nicola (2017). The Impact of External Reference Pricing within and across Countries. London School of Economics and Political Science.
  • Kanavos, Panos, Fontrier, Anna-Maria, Gill, Jennifer, Kyriopoulos, Dionysis, Boekstein, Nicola (2017). The Implementation of External Reference Pricing within and across Country Borders. London School of Economics and Political Science.
    • LSE Health
  • Fontrier, Anna-Maria, Visintin, Erica, Kanavos, Panos (2022). Similarities and differences in Health Technology Assessment systems and implications for coverage decisions: evidence from 32 countries. PHARMACOECONOMICS-OPEN, 6(3), 315 - 328. https://doi.org/10.1007/s41669-021-00311-5 picture_as_pdf
    • Social Policy
  • Fontrier, Anna-Maria, Gill, Jennifer, Kanavos, Panos (2019). International impact of external reference pricing should national policy makers care? European Journal of Health Economics, 20(8), 1147 - 1164. https://doi.org/10.1007/s10198-019-01083-w picture_as_pdf